Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 9,461 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Harrow Inc | HROW | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.09 | 0.90% | 10.09 | 08:18:32 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.00 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 45 | 9,461 | - | 7.60 - 28.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:11:14 | formt | 1,800 | $ 10.09 | USD |
Harrow Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 865.65M | 35.12M | - | 130.19M | -24.41M | -0.70 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Harrow News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HROW Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.71 | 11.23 | 9.86 | 10.35 | 556,313 | -0.62 | -5.79% |
| 1 Month | 13.52 | 13.73 | 9.86 | 11.81 | 412,502 | -3.43 | -25.37% |
| 3 Months | 9.46 | 13.73 | 9.13 | 11.30 | 479,657 | 0.63 | 6.66% |
| 6 Months | 14.11 | 14.85 | 7.60 | 10.58 | 546,579 | -4.02 | -28.49% |
| 1 Year | 24.20 | 28.25 | 7.60 | 14.40 | 537,137 | -14.11 | -58.31% |
| 3 Years | 8.33 | 28.25 | 5.40 | 13.50 | 303,696 | 1.76 | 21.13% |
| 5 Years | 4.85 | 28.25 | 3.33 | 11.33 | 258,633 | 5.24 | 108.04% |
Harrow Description
| Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits. |
